204 related articles for article (PubMed ID: 23681398)
1. Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment.
Collins ES; Galligan MC; Saldova R; Adamczyk B; Abrahams JL; Campbell MP; Ng CT; Veale DJ; Murphy TB; Rudd PM; Fitzgerald O
Rheumatology (Oxford); 2013 Sep; 52(9):1572-82. PubMed ID: 23681398
[TBL] [Abstract][Full Text] [Related]
2. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
[TBL] [Abstract][Full Text] [Related]
3. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
4. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.
Van Beneden K; Coppieters K; Laroy W; De Keyser F; Hoffman IE; Van den Bosch F; Vander Cruyssen B; Drennan M; Jacques P; Rottiers P; Verbruggen G; Contreras R; Callewaert N; Elewaut D
Ann Rheum Dis; 2009 Aug; 68(8):1360-5. PubMed ID: 18772190
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
Straub RH; Härle P; Atzeni F; Weidler C; Cutolo M; Sarzi-Puttini P
J Rheumatol; 2005 Jul; 32(7):1253-8. PubMed ID: 15996060
[TBL] [Abstract][Full Text] [Related]
6. Hospitalizations of patients treated with anti-tumor necrosis factor-α agents -- a retrospective cohort analysis.
Zisman D; Haddad A; Hashoul S; Laor A; Bitterman H; Rosner I; Eder L; Balbir-Gurman A; Mader R; Milman U
J Rheumatol; 2013 Jan; 40(1):16-22. PubMed ID: 23070992
[TBL] [Abstract][Full Text] [Related]
7. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
[TBL] [Abstract][Full Text] [Related]
8. Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.
Deyab G; Hokstad I; Aaseth J; Småstuen MC; Whist JE; Agewall S; Lyberg T; Tveiten D; Hjeltnes G; Zibara K; Hollan I
J Trace Elem Med Biol; 2018 Sep; 49():91-97. PubMed ID: 29895378
[TBL] [Abstract][Full Text] [Related]
9. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD
Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191
[TBL] [Abstract][Full Text] [Related]
10. Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis.
da Silva BS; Bonfá E; de Moraes JC; Saad CG; Ribeiro AC; Gonçalves CR; de Carvalho JF
Biologicals; 2010 Sep; 38(5):567-9. PubMed ID: 20638299
[TBL] [Abstract][Full Text] [Related]
11. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
Barra L; Pope JE; Payne M
J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
[TBL] [Abstract][Full Text] [Related]
12. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.
Omtvedt LA; Royle L; Husby G; Sletten K; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM
Arthritis Rheum; 2006 Nov; 54(11):3433-40. PubMed ID: 17075835
[TBL] [Abstract][Full Text] [Related]
13. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis.
Holman AJ; Ng E
Auton Neurosci; 2008 Dec; 143(1-2):58-67. PubMed ID: 18632310
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
15. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
[TBL] [Abstract][Full Text] [Related]
16. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study.
Klaasen R; Thurlings RM; Wijbrandts CA; van Kuijk AW; Baeten D; Gerlag DM; Tak PP
Arthritis Rheum; 2009 Nov; 60(11):3217-24. PubMed ID: 19877042
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Gülfe A; Saxne T; Geborek P
Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
[TBL] [Abstract][Full Text] [Related]
18. Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents.
Tutuncu Z; Kavanaugh A; Zvaifler N; Corr M; Deutsch R; Boyle D
Arthritis Rheum; 2005 Sep; 52(9):2693-6. PubMed ID: 16142749
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production from stimulated whole blood cultures in rheumatoid arthritis patients treated with various TNF blocking agents.
Popa C; Barrera P; Joosten LA; van Riel PL; Kullberg BJ; van der Meer JW; Netea MG
Eur Cytokine Netw; 2009 Jun; 20(2):88-93. PubMed ID: 19541595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
